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Abstract 
A transman presents for prenatal care with a 
planned, desired pregnancy and no underlying 
medical issues. Clinicians caring for him are 
initially unable to initiate a pregnancy episode in 
the electronic medical record (EMR) secondary 
to his legal designation as male, and must 
change the gender marker in the EMR to female 
in order to document the pregnancy. This 
situation illuminates the systemic challenges 
faced by transmen seeking health care, 
especially in the area of obstetrics.  This article 
will review language used to define the trans* 
community, highlight trans* healthcare 
disparities, review the context in which transmen 
receive perinatal care, discuss what is known 
about their experiences, and make 
recommendations for improvement in healthcare 
systems to eliminate barriers to safe, effective, 
and culturally-competent care. 
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The Trans* Community 
Defining the Trans* Population 
Trans* is an all-inclusive term that 
captures any individual with an internal 
gender identity that differs from the sex 
they were assigned at birth. These 
individuals can identify as the “opposite” 
gender (i.e., man or woman), as 
agender (i.e., genderfree, non-gender, 
genderless, or ungendered), as multiple 
genders (i.e., bigender or pangender), 
or as fluctuating genders (i.e., 
genderfluid or genderqueer). Many of 
these identities have recently evolved in 
conjunction with a greater societal 
understanding that gender identities fall 
along a spectrum, as opposed to a strict 
binary (female versus male).1 Cisgender 
individuals, conversely, are those whose 
internal gender identity is congruent with 
the sex they were assigned at birth.  
Transmen are defined as individuals 
who were assigned the female sex at 
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birth, but identify with a masculine 
experience of gender.2 Historically, a 
transman desiring medical means to 
affirm their gender has been referred to 
as a “female-to-male (FTM) 
transsexual.” However, this designation 
reflected a binary gender system prior to 
the evolution of newly defined non-
binary gender identities.3 The terms 
transman or trans* masculine allows for 
a diversity of experience within the 
community that at times includes the 
molding of the female/male gender 
binary into a gender spectrum. 
To reflect this increased variability, 
many trans* individuals have adopted 
the term “affirm”, as opposed to 
“transition”, as it more accurately 
conveys a sense of becoming one’s true 
self, as opposed to changing who one 
is.2 The gender affirming process, and, 
by extension, the involvement of 
healthcare professionals, differs for 
each trans* individual. Cross-sex 
hormones, gender-affirming 
(“top”/”bottom”) surgeries, 
pronoun/name changes, among other 
things are not a mandatory part of this 
process.4 Hence, the extent of medical 
intervention is determined by however 
much is required to treat an individual’s 
gender dysphoria. 
Gender dysphoria replaced the term 
Gender Identity Disorder in the 2013 
updated fifth edition of the Diagnostic 
and Statistical Manual of Mental 
Disorders (DSM-5). The diagnosis of 
gender dysphoria requires the presence 
of chronic distress and disability that 
trans* individuals often experience while 
living as a gender inconsistent with their 
internal gender identity. It is important to 
distinguish the difference between 
gender dysphoria and gender non-
conformity. Gender non-conformity is a 
non-pathologic, normal variation in 
gender expression; it is not always 
accompanied by feelings of distress or 
dysphoria.5  
Given that not all trans* individuals 
undergo gender-affirming surgeries 
including removal of their reproductive 
organs, healthcare providers must 
remain aware of the risk factors 
associated with a trans* individual’s 
biological sex (e.g., breast and cervical 
cancer for transmen, prostate cancer for 
transwomen, etc.), along with an 
awareness of the health-related risks 
specifically associated with the trans* 
community. Furthermore, many choose 
to preserve their fertility. Transmen, 
specifically, can discontinue 
testosterone treatment, which may lead 
to a resumption of the ovulatory process 
and a return of fertility. The details of 
pregnancy in transmen, along with the 
associated healthcare delivery 
considerations will be discussed in 
greater detail below. 
Estimates of the Trans* Population 
A meta-analysis of 12 prevalence 
studies found the overall calculated 
prevalence of “transsexualism” was 4.6 
in 100,000 individuals.6 Many of the 
studies included in this meta-analysis, 
however, have been criticized for using 
inadequate surrogate variables. In 
response to these critics, one review 
study utilized mathematical models to 
account for the sampling errors, 
calculating that the overall prevalence of 
trans* individuals is likely between 1 in 
500 to 1 in 2000.7 
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Historically, studies have calculated 
prevalence by varied, yet insufficient 
means.8-11 Suggestions for accurately 
calculating prevalence would require 
sampling all persons in a given area 
with a two-part question: “what sex were 
you assigned at birth?” and “what 
gender most closely aligns with your 
internal sense of gender?”8 While a 
difficult task, an accurate estimate of the 
prevalence of trans* individuals is 
essential for the adequate allocation of 
resources for trans*-specific healthcare 
needs.9  
Trans* Healthcare: An Overview 
Disparities 
Despite substantial efforts to address 
the unique healthcare needs of the 
trans* population,5 disparities continue 
to exist. Barriers include overt social 
discrimination, lack of culturally-
competent healthcare, and 
structural/legal factors (i.e., electronic 
medical records (EMR), insurance 
claims, and legal gender status).9 These 
barriers are associated with higher rates 
of psychiatric disorders,10 suicide 
attempts/ideation,11 and substance 
abuse.12 Genetics, molecular 
abnormalities, and even gender identity 
have been excluded as causes of these 
increased rates; purporting that external 
forces, often termed minority stressors, 
are the principal etiology of most 
healthcare-related disparities.13 
Adolescents and young adults in the 
trans* population are disproportionately 
more likely to experience homelessness 
compared to their cisgender peers.14 In 
addition, homeless trans* youth are 
exposed to a significantly greater 
number of health-related risks than 
homeless cisgender individuals.15 
Disparities are also found in trans* 
individuals’ personal relationships, 
reporting higher rates of intimate partner 
violence (34.6%) than any other group.16  
Infrastructural Healthcare Inadequacies 
for the Care of Trans* Individuals 
Social discrimination and minimal effort 
to provide culturally competent care has 
resulted in an infrastructure that is 
logistically unsuited for high-quality 
healthcare for trans* individuals. The 
World Professional Association for 
Transgender Health (WPATH), along 
with many other professional 
organizations, has highlighted and 
elaborated upon the inequity in care for 
the trans* population, and provided 
recommendations to address those 
inequities.2,5 In an attempt to make the 
implementation of these 
recommendations more realistic for 
healthcare organizations, many 
actionable guidelines have been 
published.17-19 
Additionally, federal law provides 
support for addressing the needs of 
trans* patients, and individual states are 
following this lead. Section 1101 of the 
Patient Protection and Affordable Care 
Act (PPACA, i.e., “Obamacare”) 
mandates insurers to cover the 
treatment of gender dysphoria through 
the elimination of denying coverage 
based upon pre-existing conditions.20 In 
2013, Congress amended the federal 
code to mandate that all federally 
funded healthcare practitioners ensure 
trans* individuals are both receiving and 
getting insurance coverage for 
necessary preventive/screening 
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procedures.21 In May of 2014, the 
Department of Health and Human 
Services eliminated the automatic 
exclusion of gender-affirming surgery for 
Medicare beneficiaries to treat gender 
dysphoria.22 As of August 2015, there 
are 6 states plus the district of Columbia 
that both ban insurance exclusion for 
transgender healthcare and provides 
transgender inclusive benefits for state 
employees.23 
With increasing insurance coverage and 
federal support for trans* care, it is 
critically important for primary care and 
Ob-Gyn providers to be aware of a 
patient’s trans* identity regardless of 
whether gender identity is openly 
discussed during the patient-provider 
interaction. Unfortunately, the EMR may 
not make that information readily known. 
Logistically, EMRs across institutions 
differ vastly, but few make the 
adjustments necessary to accommodate 
trans* individuals.24 A patient’s legal 
gender is typically reflected in the 
medical record and oftentimes one of 
the demographic variables which 
determines certain functionalities. For 
trans* patients, this attempt to make the 
EMR more streamlined and less 
cumbersome, often results in obstructed 
access to key EMR features such as 
prostate screening for transwomen or 
obstetric care for transmen. 
Recalcitrant discrimination and cultural 
insensitivity is the other chief 
fundamental barrier to providing high-
quality healthcare for trans* patients.  A 
2011 survey of greater than 6,000 trans* 
identifying patients found that 28 
percent had postponed care when sick 
or injured, and 33 percent had not 
sought preventive care due to past 
experiences of gender-based 
discrimination.25 A 2008 study of 
transmen found that while patients 
perceived preventive gynecologic care 
to be important, incorrect pronoun 
usage by medical staff and non-
inclusive health intake forms prevented 
transmen from receiving those 
services.26 This disengagement from 
healthcare results in a greater burden of 
morbidity for easily treatable medical 
problems.9 
Obstetric Care for Transmen 
What We Know About Perinatal Care for 
Transmen 
In 2009, public attention was drawn to 
the image of Thomas Beatie, a 
transgender man whose pregnancy is 
described in his memoir, “Labor of 
Love”.27 There is, however, limited 
medical and nursing literature available 
describing the experience or health 
outcomes of pregnant transmen. 
In accord with previous assumptions 
that all trans* persons desire to make 
complete anatomic “transitions” to the 
opposite gender, healthcare providers 
have historically presumed a permanent 
loss of fertility with the treatment of 
gender dysphoria.28 While this scenario 
holds true for some trans* patients, 
there are many others whose affirmed 
gender does not include gender-
affirming surgery and thus the patient 
retains natal reproductive organs. The 
medical community has not ascertained 
if there are genetic, epigenetic, or 
molecular changes to oocytes in 
response to long-term testosterone 
therapy. It is known that testosterone 
treatment may reduce fertility, though it 
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is unknown whether this effect is 
universally fully reversible if testosterone 
is stopped.29 Historically, 
recommendations have suggested that 
trans* individuals be offered the same 
opportunity to “bank” their gametes as 
would a fertile patient undergoing 
treatment for malignant disease.30 
Unfortunately, oocyte banking involves 
ovarian stimulation and egg retrieval, 
which may increase gender dysphoria 
and is often not covered by insurance 
and thus may be cost prohibitive. 
As the concept of gender non-
conformity has become more socially 
accepted, so too have the number of 
persons with stories similar to Thomas 
Beatie. Transmen with varying degrees 
of treatment for gender dysphoria have 
desired and achieved pregnancy, many 
within six months of discontinuing 
testosterone therapy.31 While transmen 
seemingly can experience a return of 
fertility in addition to normal birth 
outcomes for pregnancies, the topic 
certainly deserves more investigation. 
Because of this lack of necessary data, 
it is still important to have a discussion 
regarding fertility preservation with 
gamete banking prior to initiation of 
testosterone in transmen.  
While important to discuss fertility 
preservation, it is also critical to provide 
counseling regarding the possible 
ineffectiveness of testosterone as the 
sole method of contraception for those 
not desiring pregnancy.  Many transmen 
receiving testosterone therapy stop 
ovulating and become amenorrheic 
within 3 months.  However, ovulation 
suppression may not always occur and 
penile-vaginal intercourse may result in 
unwanted pregnancy.  This may be 
more commonplace in trans* masculine 
persons identifying as gender non-
binary and desiring a more androgynous 
physical appearance often achieved by 
receiving a low dose of testosterone, or 
transmen who miss doses of 
testosterone. 
While research is limited, there are a 
number of small studies that detail 
obstetric care of transmen. A 2014 web 
based survey of 41 pregnant 
trans*masculine participants highlighted 
the complex interplay of emotions during 
this period.31 Gender dysphoria was 
increased in some of the participants, 
while decreased in others. Interactions 
with providers varied amongst the 
participants, though it was notable that 
good interactions were marked by 
compassion, respect, gender-
appropriate language, and normalcy 
from the healthcare staff. Isolation was 
another theme that extended from 
limited transmen-specific resources, as 
well as feeling perceived lack of support. 
Participants also felt that the family 
structure was fundamentally altered in 
essential ways to create the patients 
preferred family. Some participants were 
apprehensive about those alterations, 
while others celebrated the change. 
Similarly, another 2014 qualitative study 
details the experience of eight transmen 
and gender-variant gestational parents 
who had transitioned socially or 
medically before pregnancy.32 
Loneliness was a theme throughout the 
preconception, prenatal, and postpartum 
periods, at times exacerbated by forced 
disclosure of trans* status secondary to 
being pregnant. Participants had varied 
responses to the physical changes of 
pregnancy, which were welcome to 
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some but not all. Tension points 
encountered with the healthcare system 
included discomfort and fear while 
building rapport with providers, 
communicating with office staff, 
receiving inpatient care in areas where 
patients are expected to appear female, 
accessing community resources, and 
being referred to outside providers. 
Participants did not want to overhear 
their gender identity being disclosed or 
discussed inappropriately. 
Postpartum transmen commonly desire 
to chestfeed (i.e., breastfeed) though 
success rates may depend on previous 
surgical or medical treatment. Transmen 
with prior history of testosterone 
treatment may have lower rates of 
successful chestfeeding.32 Surprisingly, 
chestfeeding may still be an option for 
transmen even if they have undergone 
male chest reconstruction.31 This new 
subset of patients presents a number of 
unique considerations for lactation 
consultants and postpartum nursing.33 
Special attention should be paid to 
asking a patient’s preferred anatomic 
terms and being ever mindful of 
pronouns.  Additionally, it is important to 
be respectful of the spectrum of 
emotions that may be evoked by 
lactation in transmen, from an increase 
in gender dysphoria to experiencing a 
newfound connection with their natal 
bodies.     
With an increasing number of transmen 
presenting for obstetric care, all 
healthcare staff involved in the 
peripartum period require sufficient 
education to create a culturally-sensitive 
and welcoming environment for trans* 
patients. No longer can assumptions be 
made regarding a pregnant patient’s 
preferred pronouns, gender identity, or 
postpartum desire to nurse one’s infant. 
Recommendations 
Electronic Medical Records 
Transmen presenting for obstetric care 
and providers aspiring to provide such 
care are greeted by the immediate 
challenge of documenting the patient’s 
pregnancy. Legal gender changes are 
often reflected in the EMR. This change 
may prevent healthcare staff from 
accessing features necessary to 
properly document obstetric care. Thus, 
proper documentation may require 
changing the patient’s gender from 
“male” to “female,” which can result in 
feelings of dysphoria and discomfort 
within the healthcare system. Similar 
themes exist for access to essential 
screening tests, as EMRs may restrict 
providers from ordering cervical pap 
smears and mammograms for patients 
designated as “male” in their chart. 
The addition of a more detailed 
sex/gender component in the patient 
demographics area would be a 
proposed solution for this obstacle. This 
is most reliably obtained by using a two-
part question regarding the patient’s 
“assigned sex at birth” (ASAB) in 
addition to the patient’s “self-identified 
gender.” In this manner, a trans* person 
is differentiated from a cisgender person 
because the answer to question one 
differs from the answer to question two. 
For example, transmen will have an 
“ASAB: female” and may answer the 
question of “self-identified gender” in a 
variety of ways:  “man,” or “transman,” 
or “non-binary.”  With this format, the 
EMR would have sufficient information 
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to allow for streamlined access to 
necessary gender affirming-related 
features, in addition to features relating 
to the patient’s ASAB. 
In addition to accurate identification of a 
patient’s sex and gender in the EMR, it 
is critically important to allow for 
documentation of preferred name. This 
functionality would benefit many 
patients, cisgender and transgender 
alike, who prefer to be called something 
different than their given name. Ideally, 
the preferred name as well as the 
patient’s assigned sex at birth and self-
identified gender would be present in a 
visible location such as the patient 
header.  
Staff Training 
In 2015, the Fenway Institute outlined a 
framework for providing culturally 
competent care for gender minorities, 
highlighting appropriate language and 
the importance of avoiding unnecessary 
questions.2 In order to assure that trans* 
patients receive high quality obstetric 
care in a welcoming environment, 
cultural competence education must be 
made a priority for the entire healthcare 
team, from front-line staff to nurses to 
licensed independent providers.  
To make staff more familiar with 
appropriate language in order to provide 
culturally sensitive care to pregnant 
transmen, and to allow time to answer 
questions regarding general trans* 
health prior to the patient's delivery, our 
institution conducted two brief training 
sessions for staff members on the labor 
and delivery unit and the postpartum 
unit. These were led by a family 
physician that cares for transgender 
patients in a specialized clinic, and a 
nurse-midwife. 
Knowledge of Resources for Trans* 
Families Experiencing Pregnancy and 
Parenthood 
Lack of resources for pregnant and 
post-partum trans* masculine patients 
may be a factor contributing to feelings 
of isolation in this population.30 It is 
prudent that providers working with 
trans* identified patients have 
knowledge about organizations 
available for peer and family support, 
mental health care including 
psychotherapy and on-going medical 
care.  A list of resources, both local and 
national, can be found in Appendix A.     
Conclusion 
While trans* masculine patients face 
social and structural barriers to culturally 
appropriate care, obstetric providers 
have the opportunity and responsibility 
to improve individual and institutional 
readiness to meet the needs of trans* 
families in the perinatal period. Our 
efforts must be interdisciplinary, 
involving all staff who have face-to-face 
encounters with families, and those who 
can effect change of the EMR 
infrastructure necessary to provide safe, 
respectful care. 
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Appendix A 
A Guide to Health Related Resources for Trans* Patients and Families  
 
PEER SUPPORT 
Local (Iowa City, IA) 
• UI TransAlliance: working to make the University of Iowa a welcoming place for 
all trans and nonbinary individuals and raise awareness of trans and nonbinary 
issues on campus and within the community. Website: 
www.facebook.com/uitransalliance  
• Trans*Verse: a support group for trans people and their allies. We work to 
extend across feelings of isolation and confusion to the connections that can 
grow through community. Website: www.facebook.com/groups/TransVerseIC/  
National 
• Gender Odyssey: an international conference focused on the needs and 
interests of transgender and gender-nonconforming people. Website: 
www.genderodyssey.org  
• Philadelphia Trans-Health Conference: a program of Mazzoni Center. This 
FREE conference offers three full days of workshops and activities focused on 
the health and well-being of transgender people and our communities. Website: 
www.trans-health.org  
 
MENTAL HEALTH CARE 
Local (Iowa City, IA) 
• University of Iowa LGBTQ Clinic in Department of Rehabilitation and 
Counseling Education (RCE): providing comprehensive clinical and 
consultation services for LGBTQ persons, their partners, and their families. 
Website: www.education.uiowa.edu/rce/family  
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MEDICAL CARE 
Local (Iowa City, IA) 
• University of Iowa LGBTQ Clinic: providing full-service health care to meet the 
LGBTQ health care needs of patients age 10 and above. Website: 
www.uilgbtqclinic.com   
National 
• University of California San Francisco Primary Care Protocol for 
Transgender Patient Care: providing accurate peer reviewed medical guidance 
for health care practitioners providing care to trans* individuals. Website: 
www.transhealth.ucsf.edu/trans?page=protocol-00-00    
 
 
